Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
4DMedical Ltd ( (AU:4DX) ) has provided an update.
4DMedical Ltd has applied to the ASX for quotation of a total of 6,117,580 new ordinary fully paid shares, issued on 15 and 16 January 2026, under its ticker 4DX. The newly quoted securities arise from the exercise or conversion of existing options or other convertible securities, modestly expanding the company’s free-float and capital base, which may enhance trading liquidity and provide additional funding flexibility for its ongoing operations and growth plans.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$4.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd is an Australian-listed medical technology company that trades on the ASX under the code 4DX. The company operates in the healthcare and medtech sector, with its activities centred on developing and commercialising advanced imaging and diagnostic solutions, particularly for respiratory and pulmonary applications.
Average Trading Volume: 5,078,969
Technical Sentiment Signal: Buy
Current Market Cap: A$2.61B
For detailed information about 4DX stock, go to TipRanks’ Stock Analysis page.